Nasal high-flow bronchodilator nebulization: a randomized cross-over study

François Réminiac(Université de Tours), Stéphan Ehrmann(Inserm)
Annals of Intensive Care
January 1, 2018
10.1186/s13613-018-0473-8
Cited by 43

Related Papers

Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19
|JAMA|2020|518
Effect of Postextubation High-Flow Nasal Oxygen With Noninvasive Ventilation vs High-Flow Nasal Oxygen Alone on Reintubation Among Patients at High Risk of Extubation Failure
|JAMA|2019|353
Non-invasive ventilation versus high-flow nasal cannula oxygen therapy with apnoeic oxygenation for preoxygenation before intubation of patients with acute hypoxaemic respiratory failure: a randomised, multicentre, open-label trial
|The Lancet Respiratory Medicine|2019|176
Spontaneous-Breathing Trials with Pressure-Support Ventilation or a T-Piece
|New England Journal of Medicine|2022|174
Effect of High-Flow Nasal Cannula Oxygen vs Standard Oxygen Therapy on Mortality in Patients With Respiratory Failure Due to COVID-19
|JAMA|2022|130